First-in-Class PAM Targeting Adenosine 2A Receptor: Developmental Candidate Selection and Validation of Autoimmune Disease Indications

Forschungsstelle

INNOSUISSE

Projektnummer

121.127 IP-LS

Projekttitel

First-in-Class PAM Targeting Adenosine 2A Receptor: Developmental Candidate Selection and Validation of Autoimmune Disease Indications

Projekttitel Englisch

First-in-Class PAM Targeting Adenosine 2A Receptor: Developmental Candidate Selection and Validation of Autoimmune Disease Indications

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Schlüsselwörter	-	-	-
Abstract	-	-	-

Kategorie	Text
Schlüsselwörter (Englisch)	Life sciences, Pharmaceuticals
Abstract (Englisch)	Adenosine 2A receptor (A2AR) signaling dysregulation results in inflammatory diseases. This project focuses on reaching the developmental drug candidate stage for positive allosteric modulators (PAMs) for A2AR and selecting the most relevant inflammatory therapeutic area(s) for their application.